<DOC>
	<DOCNO>NCT00771446</DOCNO>
	<brief_summary>Evaluate well ELAD system work treat people liver failure .</brief_summary>
	<brief_title>Safety &amp; Efficacy Extracorporeal Liver Assist Device ( ELAD ) System Patients With Hepatic Insufficiency</brief_title>
	<detailed_description>This multicenter , open-label , randomize , concurrent control study subject acute chronic hepatitis . Subjects meet eligibility requirement study randomly assign 2:1 ratio receive either standard medical therapy acute liver failure plus ELAD system , standard medical therapy alone , latter defined conventional therapy acute chronic hepatitis determine clinically appropriate treat physician . Immediately prior treatment initiation , subject eligibility confirm . Treatment ELAD continue minimum 3 day maximum 10 day clinical status improve relative study entry . Subjects follow 30 day elapse since study enrollment ( control ) 30 day elapse since cessation ELAD therapy ( ELAD group ) , whichever come first .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatic Insufficiency</mesh_term>
	<mesh_term>Pentoxifylline</mesh_term>
	<criteria>1 . Weight &gt; 40 kilogram 2 . Age &gt; 18 &lt; 70 year 3 . Acute decompensation cirrhosis precede 4872 hour period 4 . Up 4 week symptom onset presentation 5 . Presence precipitate event 6 . Either MELD score ≥32 , ≥24 one follow Severe encephalopathy grade 3 4 Westhaven scale Renal dysfunction typical type1 hepatorenal syndrome , i.e . acute renal failure without evidence elevate serum creatinine ( &gt; 2.5mg/dL ) 1 6 month prior study entry . Serum creatinine study entry &gt; 2.5mg/dL exclude subject enrolment 7 . SOFA score ≥9 initial Screening Visit 1 . Platelets &lt; 50,000 reduce &lt; 80,000 72 hour period 2 . Renal failure : Serum creatinine ≥2.5 mg/dL measure 1 6 month period prior study entry . If subject contraindication renal replacement therapy ( hemodialysis hemofiltration ) , subject exclude entry study 3 . Active sepsis . Sepsis define positive microbiological culture , ascitic white cell count &gt; 450 cells/mm³ ( ascitic neutrophil count &gt; 250 cells/mm³ ) , clinical sign chest xray appearance least 48 hour without clinical improvement prior randomization , evidence infection control 4 . Evidence major hemorrhage indicate require ≥ 4 unit blood transfusion within 24 hour period , hemodynamic instability ( sustain pulse &gt; 120 beats/min systolic blood pressure &lt; 100 mmHg one hour ) . Subjects recent history gastrointestinal hemorrhage successfully treat remain hemodynamically stable period 48 hour eligible study 5 . Evidence ( physical exam , history , laboratory evaluation ) significant concomitant disease include chronic congestive heart failure , vascular disease , emphysema , AIDS , fattyliver disease nonalcoholic origin , hepatitis due herpes virus , Wilson 's disease , BuddChiari syndrome ; 6 . Known history hepatocellular carcinoma beyond Milan criterion and/or portal vein thrombosis 7 . Evidence Small Bowel Perforation within 48 hour treatment ; 8 . Evidence brain death determine blood flow study positive herniation and/or absence pupillary reflex 9 . Mean Arterial Pressures ( MAP ) &lt; 50 mm Hg one hour longer ; 10 . Requirement escalate dos vasopressor support alphaadrenergic agent one hour long evidence hemodynamic instability ; 11 . Clinical radiographic evidence new stroke intracerebral bleed 12 . Seizures uncontrolled medication 13 . Acute myocardial infarction base clinical and/or electrocardiographic evidence 14 . Lung disease define PaO2 &lt; 60 mm Hg history severe COPD interstitial lung disease 15 . Pregnancy determine βHCG result , lactation 16 . Participation another investigational drug , biologic , device study within one month enrollment</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Hepatitis , acute</keyword>
	<keyword>Acute Hepatitis OR Chronic Hepatitis</keyword>
</DOC>